FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/102408 [Registered on: 29/01/2026] Trial Registered Prospectively
Last Modified On: 29/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparison of two medicines that is Dexmedetomidine and Midazolam added to local anaesthetic to make forearm surgeries more comforatble and pain free .  
Scientific Title of Study   A prospective,randomized,double blind study to compare between Dexmedetomidine and Midazolam as an adjuvant to Bupivacaine (0.5 percent) in ultrasound guided supraclavicular brachial plexus block for forearm surgeries 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr RAVI RAJSHEKHAR BALLURGI 
Designation  Resident Doctor 
Affiliation  Vilasrao Deshmukh Government Medical College,Latur 
Address  Department of Anaesthesiology, Surgical building,First Floor,Government Medical College,Latur.

Latur
MAHARASHTRA
413512
India 
Phone  9503698766  
Fax    
Email  raviballurgi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr SUREKHA VYANKATRAO MORE 
Designation  Assistant Professor 
Affiliation  Vilasrao Deshmukh Government Medical College,Latur 
Address  Department of Anaesthesiology, Surgical building,First Floor,Government Medical College,Latur.

Latur
MAHARASHTRA
413512
India 
Phone  9422741346  
Fax    
Email  desurekha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr SUREKHA VYANKATRAO MORE 
Designation  Assistant Professor 
Affiliation  Vilasrao Deshmukh Government Medical College,Latur 
Address  Department of Anaesthesiology, Surgical building,First Floor,Government Medical College,Latur.

Latur
MAHARASHTRA
413512
India 
Phone  9422741346  
Fax    
Email  desurekha@gmail.com  
 
Source of Monetary or Material Support  
Vilasrao Deshmukh Government Medical College,Latur, Maharashtra, India. 413512 
 
Primary Sponsor  
Name  Vilasrao Deshmukh Government Medical College, Latur 
Address  Near Rajasthan Vidyalaya,Gandhi Chowk, Latur, Maharashtra, India.413512. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr RAVI BALLURGI   Vilasrao Deshmukh Government Medical College Latur   Surgery Operation theatre, 1st Floor,Surgical building, VDGMC, Latur
Latur
MAHARASHTRA 
9503698766

raviballurgi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, VDGMC,Latur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S520||Fracture of upper end of ulna, (2) ICD-10 Condition: S518||Open wound of forearm, (3) ICD-10 Condition: S562||Injury of other flexor muscle, fascia and tendon at forearm level, (4) ICD-10 Condition: S621||Fracture of other and unspecifiedcarpal bone(s),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  DEXMEDETOMIDINE  Adding Dexmedetomidine 1 microgram per kg body weight as an adjuvant to Bupivacain (0.5 percent) 15 ml as a single dose in ultrasound guided Supraclavicular brachial plexus block in forearm surgeries. 
Comparator Agent  MIDAZOLAM  Adding Midazolam 50 microgram per kg body weight as an adjuvant to Bupivacain (0.5 percent) 15 ml as a single dose in ultrasound guided Supraclavicular brachial plexus block in forearm surgeries. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  American Society of Anaesthesiologist (ASA) physical status I or II,
Weight more than 40 kg,
Those willing to participate in the study. 
 
ExclusionCriteria 
Details  Patient refusal,
Study drug contraindicated or Contraindications to regional anaesthesia,
Patients with coagulation disorders,local Skin infection, those who are morbidly obese, hemodynamically unstable,
ASA Physical status more than II. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of analgesia.  From Local Anesthetic administration to 2,4,6,8,10,12,18hours till complete recovery of anesthesia on all nerves and complete recovery of Motor function of the hand and the forearm. 
 
Secondary Outcome  
Outcome  TimePoints 
Onset of Analgesia  from Local Anaesthetic administration to the onset of analgesia at 5,10,15,20 minutes. 
Hemodynamic changes like Heart rate, Systolic blood pressure,Diastolic blood pressure, SPO2  From Local Anaesthetic Administration to 5,10,15,30,60 minutes and every half hourly thenafter 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   10/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Regional Anaesthesia technique have gained significant popularity due to their numerous benefits over general anaesthesia and systemic analgesia. Supraclavicular brachial plexus block is amongst the regional ananesthesia technique used most commonly for upper limb surgeries. But to increase post operative analgesia and for post operative patient satisfaction , only Bupivacain is not sufficient. 
So many adjuvants were tried along with Bupivacain in supraclavicular brachial plexus block.
 In my study, I have compared effect of Dexmedetomidine and Midazolam as an adjuvant to Bupivacain 0.5 percent in ultrasound guided supraclavicular brachial plexus block for forearm surgeries.
 I have compared onset of analgesia, hemodynamic parameters and total duration of post operative analgesia in Dexmedetomidine group and in Midazolam group.
 
Close